查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1808900

止血诊断市场（按测试、按产品类型、按最终用户、按国家和地区）- 2024 年至 2032 年的行业分析、市场规模、市场份额和预测

Hemostasis Diagnostics Market, By Test, By Product Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年止血诊断市场规模价值 11.9023 亿美元，2025 年至 2032 年的复合年增长率为 4.59%。

止血诊断涉及人体止血能力（或换句话说，凝血系统功能）的医学检测和评估。这些诊断对于识别出血性疾病、血栓等凝血障碍以及监测正在接受抗凝血剂（例如血液稀释剂）治疗的患者至关重要。

止血诊断市场-市场动态

慢性病和血液疾病的盛行率不断上升，以及对止血检测的高需求预计将推动市场需求

血友病、血管性血友病、血小板减少症和深部静脉栓塞 (DVT) 等出血和凝血障碍的发生率不断上升，推动了止血诊断市场的发展。根据世界血友病联盟统计，全球有超过 40 万人患有血友病，其中许多人需要定期监测和检测，这推动了市场的成长。此外，心血管疾病、肝病和癌症患者也需要定期进行凝血功能检测，以预防或控制血栓形成或出血等併发症。例如，接受化疗的癌症患者的凝血功能可能发生变化，因此需要定期进行诊断检测。老年人更容易出现凝血问题，许多人需要接受抗凝血治疗，以应对心房颤动、中风预防、术后治疗等情况。随着外科手术（尤其是骨科和心血管外科手术）的增多，术前凝血功能筛检的应用也越来越广泛，这进一步刺激了对止血诊断的需求。

此外，全球日益认识到早期发现和管理出血和凝血障碍的重要性。政府计画、卫生组织的倡导以及医疗宣传活动提高了公众和临床对这些疾病的认识。因此，筛检和诊断率有所提高，尤其是在已开发国家和中等收入国家。此外，TEG（血栓弹力图）和ROTEM（旋转血栓弹力图）等黏弹性测试技术的引入，彻底改变了重症监护、外科和创伤环境中的凝血监测。这些测试提供了血栓形成和溶解的动态即时视图，从而能够更快地做出临床决策。

止血诊断市场－关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2024-2032 年）的年复合成长率约为 4.59%。

根据测试细分，预计凝血酶原时间测试部分将在 2024 年占据最大市场份额，因为它易于使用、成本效益高，且只需极少的培训。

根据产品类型细分，消耗品细分市场是 2024 年的主要产品类型，因为随着全球医疗保健服务的普及，对消耗品的需求很高。

根据最终用户细分，医院部门是 2024 年领先的最终用户，因为医院需要诊断和管理凝血障碍。

从地区来看，由于静脉血栓和心房颤动盛行率高，北美将成为 2024 年的主要收入来源。

止血诊断市场-細項分析：

全球止血诊断市场根据测试、产品类型、最终用户和地区进行细分。

根据检测项目，市场可分为五类：凝血酶原时间检测、纤维蛋白原检测、D-二聚体检测、活化部分凝血活酶时间检测及其他。其中，凝血酶原时间检测占市场主导地位。出血性疾病和肝病盛行率的上升正在推动该领域的需求。

依产品类型，市场分为三类：耗材、实验室分析仪和即时检测系统。耗材部分占据市场主导地位。耗材在凝血检测和维持标准诊断结果方面发挥着至关重要的作用。

根据最终用户，市场分为三类：医院、诊断实验室和其他。医院部门占据市场主导地位，预计在预测期内仍将保持高主导地位。医院重症监护和急诊室的需求不断增长，推动着市场的成长。

止血诊断市场—地理洞察

在全球范围内，止血诊断市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。北美在全球止血诊断市场中占有最大的份额。仅美国就占据了相当大的份额，这得益于其高昂的医疗支出、先进的诊断基础设施以及主要参与者的强大影响力。欧洲由于静脉血栓栓塞症 (VTE) 和年龄相关性出血性疾病的发生率高，因此占有相当大的收入份额。欧洲拥有完善的医院和诊断实验室网路。亚太地区是止血诊断市场成长最快的地区。快速的城市化、人口老化以及医疗服务覆盖范围的扩大是推动成长的因素。

止血诊断市场-竞争格局：

凝血诊断市场竞争激烈，技术驱动，其特征是全球诊断巨头、区域性企业以及越来越多的专业医疗器材公司。各公司也专注于策略合作伙伴关係、併购和新产品开发，以增强其全球影响力和市场份额。各公司正在开发用于近患者检测的便携式凝血诊断设备，尤其是在急诊室和外科手术环境中。例如，贝克曼库尔特和罗氏正在投资用于多诊断资料管理的整合式数位平台。

最新动态：

2024 年 4 月，Haemonetics Corporation 的 Global Hemostasis-HN 检测试剂盒获得了美国 FDA 批准。

2024年9月，Sysmex Corporation推出了HISCL HIT IgG检测试剂盒，可以检测接受肝素治疗的患者的IgG抗体。

目录

第 1 章：止血诊断市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 止血诊断市场测试片段
    • 止血诊断市场片段（依产品类型）
    • 止血诊断市场片段（按最终用户）
    • 各国止血诊断市场概况
    • 止血诊断市场（按地区）
  • 竞争洞察

第三章：止血诊断关键市场趋势

  • 止血诊断市场驱动因素
    • 市场驱动因素的影响分析
  • 止血诊断市场限制
    • 市场限制的影响分析
  • 止血诊断市场机会
  • 止血诊断市场未来趋势

第四章：止血诊断产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：止血诊断市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长细分市场
    • 最鬆散的细分市场
    • 边际损失部分

第六章：止血诊断市场格局

  • 2024年止血诊断市占分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：止血诊断市场 - 按测试

  • 概述
    • 按测试进行细分份额分析
    • 凝血酶原时间检测
    • 纤维蛋白原检测
    • D-二聚体检测
    • 活化部分凝血活酶时间试验
    • 其他的

第 8 章：止血诊断市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 耗材
    • 实验室分析仪
    • PoC 测试系统

第九章：止血诊断市场－按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院
    • 诊断实验室
    • 其他的

第 10 章：止血诊断市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美止血诊断主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按测试）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲止血诊断主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按测试）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区止血诊断主要製造商
    • 亚太市场规模及预测（按国家/地区）
    • 亚太市场规模及预测（按测试）
    • 亚太市场规模及预测（依产品类型）
    • 亚太市场规模及预测（依最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲止血诊断主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模和预测（按测试）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的止血诊断主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模和预测（按测试）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：主要供应商分析-止血诊断产业

  • 竞争仪錶板
  • 公司简介
    • Siemens Healthineers
    • Roche Diagnostics
    • Sysmex Corporation
    • Werfen Group
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Beckman Coulter
    • Diagnostica Stago
    • HemoSonics (Stago Group)
    • Horiba Medical
    • Trinity Biotech
    • Helena Laboratories
    • BioMerieux
    • BD
    • Grifols SA
    • Medtronic
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5519

Hemostasis Diagnostics Market size was valued at USD 1,190.23 Million in 2024, expanding at a CAGR of 4.59% from 2025 to 2032.

Hemostasis diagnostics involves medical testing and evaluation of the body's ability to stop bleeding, or in other words, how well the blood clotting (coagulation) system is functioning. These diagnostics are crucial in identifying bleeding disorders, clotting disorders like thrombosis, and monitoring patients on anticoagulants such as blood-thinning therapies.

Hemostasis Diagnostics Market- Market Dynamics

Growing prevalence of chronic & blood disorders and high demand from hemostasis testing are expected to propel market demand

Hemostasis diagnostics market is driven by the growing incidence of bleeding and clotting disorders such as hemophilia, von Willebrand disease, thrombocytopenia, and deep vein thrombosis (DVT). According to the World Federation of Hemophilia, over 400,000 people are living with hemophilia globally, many of whom require regular monitoring and testing, fueling market growth. In addition, cardiovascular diseases, liver, cancer conditions require regular coagulation testing to prevent or manage complications like thrombosis or hemorrhage. For example, cancer patients undergoing chemotherapy may have altered coagulation profiles, necessitating regular diagnostic testing. Older adults are more prone to blood coagulation issues, and many require anticoagulant therapy for conditions such as atrial fibrillation, stroke prevention, and after surgical procedures. The increase in surgeries, particularly orthopedic and cardiovascular surgeries, has led to greater use of pre-operative coagulation screening, further fueling demand for hemostasis diagnostics.

Further, there is a growing global awareness of the importance of early detection and management of bleeding and clotting disorders. Government programs, advocacy by health organizations, and medical campaigns have improved public and clinical understanding of these conditions. As a result, screening and diagnostic rates have improved, especially in developed and middle-income countries. Moreover, the introduction of viscoelastic testing technologies such as TEG (Thromboelastography) and ROTEM (Rotational Thromboelastometry) has revolutionized coagulation monitoring in critical care, surgery, and trauma settings. These tests provide a dynamic and real-time view of clot formation and dissolution, enabling faster clinical decision-making.

Hemostasis Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.59% over the forecast period (2024-2032)

Based on Test segmentation, prothrombin time test segment was predicted to show maximum market share in the year 2024, owing to its ease of use and high-cost effectiveness with minimal training.

Based on Product Type segmentation, consumables segment was the leading Product Type in 2024, due to high demand for consumables as healthcare access increases across the globe.

Based on End User segmentation, hospitals segment was the leading End User in 2024, owing to need for diagnosis & managing coagulation disorders at hospitals.

On the basis of the region, North America was the leading revenue generator in 2024, owing to high prevalence of vein thrombosis & atrial fibrillation.

Hemostasis Diagnostics Market- Segmentation Analysis:

The Global Hemostasis Diagnostics Market is segmented on the basis of Test, Product Type, End User, and Region.

The market is divided into five categories based on Test: prothrombin time test, fibrinogen test, D-dimer test, activated partial thromboplastin time test, and others. The prothrombin time test segment dominates the market. Increasing prevalence of bleeding disorders, liver diseases is boosting segment demand.

The market is divided into three categories based on Product Type: consumables, laboratory analyzers, and PoC testing systems. The consumables segment dominates the market. Consumables play vital role in coagulation testing and maintaining standard diagnostic results.

The market is divided into three categories based on the End User: hospitals, diagnostic laboratories, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. Growing demand from critical care & emergency settings in hospitals is fueling market growth.

Hemostasis Diagnostics Market- Geographical Insights

Worldwide, the Hemostasis Diagnostics market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa North America holds the largest market share globally in hemostasis diagnostics. The U.S. alone accounts for a significant portion due to its high healthcare spending, advanced diagnostic infrastructure, and strong presence of key players. Europe holds significant revenue share due to high incidence of venous thromboembolism (VTE) and age-related bleeding disorders. Well-established hospital and diagnostic laboratory networks. Asia Pacific is the fastest-growing region in the hemostasis diagnostics market. Rapid urbanization, aging population, and expanding access to healthcare services are driving growth.

Hemostasis Diagnostics Market- Competitive Landscape:

The hemostasis diagnostics market is highly competitive and technology-driven, characterized by the presence of global diagnostic giants, regional players, and a growing number of specialized medical device companies. Companies are also focusing on strategic partnerships, mergers, and new product development to strengthen their global presence and market share. Companies are developing portable hemostasis diagnostic devices for near-patient testing, especially in emergency rooms and surgical settings. For example, Beckman Coulter and Roche are investing in integrated digital platforms for multi-diagnostic data management.

Recent Developments:

In April 2024, Haemonetics Corporation received an U.S. FDA clearance for its Global Hemostasis-HN assay cartridge.

In September 2024, Sysmex Corporation introduced HISCL HIT IgG Assay Kit, that enables the detection of IgG antibodies for patients undergoing heparin therapy.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET KEY PLAYERS

  • Siemens Healthineers
  • Roche Diagnostics
  • Sysmex Corporation
  • Werfen Group
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Beckman Coulter
  • Diagnostica Stago
  • HemoSonics (Stago Group)
  • Horiba Medical
  • Trinity Biotech
  • Helena Laboratories
  • BioMerieux
  • BD
  • Grifols S.A.
  • Medtronic
  • Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY TEST- MARKET ANALYSIS, 2019-2032

  • Prothrombin time test
  • Fibrinogen test
  • D-dimer test
  • Activated partial thromboplastin time test
  • Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Consumables
  • Laboratory analyzers
  • PoC testing systems

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Diagnostic laboratories
  • Others

GLOBAL HEMOSTASIS DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemostasis Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemostasis Diagnostics Market Snippet by Test
    • 2.1.2. Hemostasis Diagnostics Market Snippet by Product Type
    • 2.1.3. Hemostasis Diagnostics Market Snippet by End User
    • 2.1.4. Hemostasis Diagnostics Market Snippet by Country
    • 2.1.5. Hemostasis Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemostasis Diagnostics Key Market Trends

  • 3.1. Hemostasis Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemostasis Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemostasis Diagnostics Market Opportunities
  • 3.4. Hemostasis Diagnostics Market Future Trends

4. Hemostasis Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemostasis Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Hemostasis Diagnostics Market Landscape

  • 6.1. Hemostasis Diagnostics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemostasis Diagnostics Market - By Test

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test, 2024 & 2032 (%)
    • 7.1.2. Prothrombin time test
    • 7.1.3. Fibrinogen test
    • 7.1.4. D-dimer test
    • 7.1.5. Activated partial thromboplastin time test
    • 7.1.6. Others

8. Hemostasis Diagnostics Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Consumables
    • 8.1.3. Laboratory analyzers
    • 8.1.4. PoC testing systems

9. Hemostasis Diagnostics Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Diagnostic laboratories
    • 9.1.4. Others

10. Hemostasis Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Hemostasis Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Hemostasis Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Hemostasis Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Hemostasis Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Hemostasis Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Hemostasis Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Siemens Healthineers
    • 11.2.2. Roche Diagnostics
    • 11.2.3. Sysmex Corporation
    • 11.2.4. Werfen Group
    • 11.2.5. Abbott Laboratories
    • 11.2.6. Thermo Fisher Scientific
    • 11.2.7. Beckman Coulter
    • 11.2.8. Diagnostica Stago
    • 11.2.9. HemoSonics (Stago Group)
    • 11.2.10. Horiba Medical
    • 11.2.11. Trinity Biotech
    • 11.2.12. Helena Laboratories
    • 11.2.13. BioMerieux
    • 11.2.14. BD
    • 11.2.15. Grifols S.A.
    • 11.2.16. Medtronic
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us